No Data
First Solar, Frontier Communications, and More Stocks See Action From Activist Investors -- Barrons.com
Amazon To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Wednesday
Bicycle Therapeutics Is Maintained at Market Outperform by JMP Securities
JMP Securities Maintains Bicycle Therapeutics(BCYC.US) With Buy Rating, Cuts Target Price to $26
Analysts Offer Insights on Healthcare Companies: Century Therapeutics (IPSC), Incyte (INCY) and Bicycle Therapeutics (BCYC)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Zoetis (ZTS), Walgreens Boots Alliance (WBA) and Bicycle Therapeutics (BCYC)